Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Phase I Clinical Trial of Crotoxin in Patients With Advanced Cancer Using an Intravenous Route of Administration

NCT01481532 is registered in ClinicalTrials.gov with Celtic Biotech Ltd as lead sponsor.

NCT NCT01481532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01481532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Phase I Clinical Trial of Crotoxin in Patients With Advanced Cancer Using an Intravenous Route of Administration
Lead sponsor
Celtic Biotech Ltd
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
November 30, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer